The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utility of [18F]FDG PET/CT in predicting pathological complete response to neoadjuvant therapy in breast cancer: A prospective study.
 
Fabrizia Gelardi
No Relationships to Disclose
 
Martina Sollini
No Relationships to Disclose
 
Roberta Zanca
No Relationships to Disclose
 
Paola Tiberio
No Relationships to Disclose
 
Rita De Sanctis
No Relationships to Disclose
 
Bethania Fernandes
No Relationships to Disclose
 
Marcello Rodari
No Relationships to Disclose
 
Arturo Chiti
Consulting or Advisory Role - Novartis; Telix Pharmaceuticals
Speakers' Bureau - Amgen; GE Healthcare; Novartis; Sirtex Medical
 
Lidija Antunovic
No Relationships to Disclose
 
Armando Santoro
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Incyte; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda